Sit Investment Associates Inc. Acquires 11,749 Shares of Stryker Corporation $SYK

Sit Investment Associates Inc. boosted its holdings in Stryker Corporation (NYSE:SYK) by 41.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 40,152 shares of the medical technology company’s stock after purchasing an additional 11,749 shares during the period. Sit Investment Associates Inc.’s holdings in Stryker were worth $14,112,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MidFirst Bank bought a new stake in Stryker during the 4th quarter valued at $319,000. Astoria Portfolio Advisors LLC. boosted its holdings in shares of Stryker by 2.6% during the fourth quarter. Astoria Portfolio Advisors LLC. now owns 2,425 shares of the medical technology company’s stock worth $933,000 after purchasing an additional 62 shares during the period. Pacer Advisors Inc. boosted its holdings in shares of Stryker by 6.4% during the fourth quarter. Pacer Advisors Inc. now owns 29,536 shares of the medical technology company’s stock worth $10,381,000 after purchasing an additional 1,768 shares during the period. Virtu Financial LLC grew its stake in shares of Stryker by 150.8% in the fourth quarter. Virtu Financial LLC now owns 4,895 shares of the medical technology company’s stock worth $1,720,000 after purchasing an additional 2,943 shares during the last quarter. Finally, MV Capital Management Inc. bought a new stake in shares of Stryker in the fourth quarter worth about $159,000. Institutional investors own 77.09% of the company’s stock.

Insiders Place Their Bets

In other news, Director Ronda E. Stryker sold 310,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the transaction, the director owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP M Kathryn Fink sold 5,220 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total value of $1,481,697.00. Following the completion of the transaction, the vice president owned 13,137 shares of the company’s stock, valued at $3,728,937.45. This represents a 28.44% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 323,264 shares of company stock valued at $100,659,489. Insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Robert W. Baird set a $385.00 price target on Stryker in a research report on Friday, May 1st. Citigroup cut their price objective on Stryker from $420.00 to $385.00 and set a “buy” rating on the stock in a research report on Tuesday, April 7th. Jefferies Financial Group reissued a “buy” rating and set a $465.00 target price on shares of Stryker in a research note on Wednesday, March 4th. Needham & Company LLC decreased their target price on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Sanford C. Bernstein set a $410.00 price target on Stryker in a research note on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Stryker has an average rating of “Moderate Buy” and a consensus target price of $395.33.

Stryker Price Performance

Shares of SYK stock opened at $308.62 on Friday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The business’s fifty day moving average is $314.43 and its 200 day moving average is $341.94. The stock has a market cap of $118.31 billion, a price-to-earnings ratio of 35.72, a PEG ratio of 1.93 and a beta of 0.78. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same period in the previous year, the firm earned $2.84 EPS. The company’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Research analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.